Home/Filings/4/0000950103-22-000900
4//SEC Filing

Spurr Robert 4

Accession 0000950103-22-000900

CIK 0000885590other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 7:55 PM ET

Size

15.1 KB

Accession

0000950103-22-000900

Insider Transaction Report

Form 4
Period: 2022-01-18
Spurr Robert
President, Salix
Transactions
  • Sale

    Common Shares, No Par Value

    2022-01-18$26.63/sh3,251$86,57463,550 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.

Issuer

Bausch Health Companies Inc.

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001543795

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 7:55 PM ET
Size
15.1 KB